• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » May-June 2019 (Volume 20, Number 3) : PDF
May-June 2019 (Volume 20, Number 3)     : PDF

May-June 2019 (Volume 20, Number 3) : PDF

$59.00

Product Details

Evaluating data quality: Integrity, reliability, accessibility
Not all data are created equal, and clinical trial professionals must be able to recognize when the data they collect have value and when they don’t.

A new look at clinical trial compensation for participants
When it comes to offering to pay clinical trial subjects to participate, the line between compensation and coercion is difficult to draw but all too easy to cross.

The case for paying trial completion bonuses
Completion bonuses are one particular type of compensation for clinical trial participants that institutional review boards (IRBs) sometimes reject. Researchers recently argued that with the appropriate safeguards, however, “completion bonuses” are not coercive and are unlikely to be unduly influential.

  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing